Ferritin

Last updated

Ferritin
Ferritin.png
Structure of the murine ferritin complex [1]
Identifiers
SymbolFerritin
Pfam PF00210
Pfam clan CL0044
InterPro IPR008331
SCOP2 1fha / SCOPe / SUPFAM
Available protein structures:
Pfam   structures / ECOD  
PDB RCSB PDB; PDBe; PDBj
PDBsum structure summary
ferritin, light polypeptide
Identifiers
Symbol FTL
NCBI gene 2512
HGNC 3999
OMIM 134790
RefSeq NM_000146
UniProt P02792
Other data
Locus Chr. 19 q13.3–13.4
Search for
Structures Swiss-model
Domains InterPro
ferritin, heavy polypeptide 1
Identifiers
Symbol FTH1
Alt. symbolsFTHL6
NCBI gene 2495
HGNC 3976
OMIM 134770
RefSeq NM_002032
UniProt P02794
Other data
Locus Chr. 11 q13
Search for
Structures Swiss-model
Domains InterPro
ferritin mitochondrial
Mitochondrial Ferritin.png
Crystallographic structure of mitochondrial ferritin. [2]
Identifiers
SymbolFTMT
NCBI gene 94033
HGNC 17345
OMIM 608847
RefSeq NM_177478
UniProt Q8N4E7
Other data
Locus Chr. 5 q23.1
Search for
Structures Swiss-model
Domains InterPro

Ferritin is a universal intracellular and extracellular protein that stores iron and releases it in a controlled fashion. The protein is produced by almost all living organisms, including archaea, bacteria, algae, higher plants, and animals. It is the primary intracellular iron-storage protein in both prokaryotes and eukaryotes, keeping iron in a soluble and non-toxic form. In humans, it acts as a buffer against iron deficiency and iron overload. [3]

Contents

Ferritin is found in most tissues as a cytosolic protein, but small amounts are secreted into the serum where it functions as an iron carrier. Plasma ferritin is also an indirect marker of the total amount of iron stored in the body; hence, serum ferritin is used as a diagnostic test for iron-deficiency anemia and iron overload. [4] Aggregated ferritin transforms into a water insoluble, crystalline and amorphous form of storage iron called hemosiderin. [5]

Ferritin is a globular protein complex consisting of 24 protein subunits forming a hollow spherical nanocage with multiple metal–protein interactions. [6] Ferritin with iron removed is called apoferritin. [7] :e10

Gene

Ferritin genes are highly conserved between species. All vertebrate ferritin genes have three introns and four exons. [8] In human ferritin, introns are present between amino acid residues 14 and 15, 34 and 35, and 82 and 83; in addition, there are one to two hundred untranslated bases at either end of the combined exons. [9] The tyrosine residue at amino acid position 27 is thought to be associated with biomineralization. [10]

Protein structure

Ferritin is a hollow globular protein of mass 474  kDa and comprising 24 subunits. Typically it has internal and external diameters of about 8 and 12 nm, respectively. [11] The nature of these subunits varies by class of organism:

All the aforementioned ferritins are similar, in terms of their primary sequence, with the vertebrate H-type. [12] In E. coli, a 20% similarity to human H-ferritin is observed. [12] Some ferritin complexes in vertebrates are hetero-oligomers of two highly related gene products with slightly different physiological properties. The ratio of the two homologous proteins in the complex depends on the relative expression levels of the two genes.

Cytosolic ferritin shell (apoferritin) is a heteropolymer of 24 subunits of heavy (H) and light (L) peptides that form a hollow spherical nanocage that covers an iron core composed of crystallites together with phosphate and hydroxide ions. The resulting particle is similar to ferrihydrite (5Fe2O3·9H2O). Each ferritin complex can store about 4500 iron (Fe3+) ions. [9] [12] The proportion of H to L subunits varies in ferritin from different tissues, explaining its heterogeneity on isoelectric focusing. L-rich ferritins (from spleen and liver) are more basic than H-rich ferritins (from heart and red blood cells).

Serum ferritin, which is typically iron-poor, consists almost exclusively of L subunits. Serum ferritin is heterogeneous due to glycosylation. The glycosylation and direct relationship of serum ferritin concentration to iron storage in macrophages suggest it is secreted by macrophages in response to changing iron levels.

Human mitochondrial ferritin , MtF, was found to express as a pro-protein. [14] When a mitochondrion takes it up, it processes it into a mature protein similar to the ferritins found in the cytoplasm, which it assembles to form functional ferritin shells. Unlike other human ferritins, it is a homopolymer of H type ferritin and appears to have no introns (intronless) in its genetic code. The mitochondrial ferritin's Ramachandran plot [15] shows its structure to be mainly alpha helical with a low prevalence of beta sheets. It accumulates in large amounts in the erythroblasts of subjects with impaired heme synthesis.

Function

Iron storage

Iron uptake through the 3-fold channel of ferritin Ferritin 3foldchannel.png
Iron uptake through the 3-fold channel of ferritin

Ferritin is present in every cell type. [9] It serves to store iron in a non-toxic form, to deposit it in a safe form, and to transport it to areas where it is required. [16] The function and structure of the expressed ferritin protein varies in different cell types. This is controlled primarily by the amount and stability of messenger RNA (mRNA), but also by changes in how the mRNA is stored and how efficiently it is transcribed. [9] One major trigger for the production of many ferritins is the mere presence of iron; [9] an exception is the yolk ferritin of Lymnaea sp., which lacks an iron-responsive unit. [12]

Free iron is toxic to cells as it acts as a catalyst in the formation of free radicals from reactive oxygen species via the Fenton reaction. [17] Hence vertebrates have an elaborate set of protective mechanisms to bind iron in various tissue compartments[ discuss ]. Within cells, iron is stored in a protein complex as ferritin or the related complex hemosiderin. Apoferritin binds to free ferrous iron and stores it in the ferric state. As ferritin accumulates within cells of the reticuloendothelial system, protein aggregates are formed as hemosiderin. Iron in ferritin or hemosiderin can be extracted for release by the RE cells, although hemosiderin is less readily available. Under steady-state conditions, the level of ferritin in the blood serum correlates with total body stores of iron; thus, the serum ferritin FR5Rl is the most convenient laboratory test to estimate iron stores.[ citation needed ]

Because iron is an important mineral in mineralization, ferritin is employed in the shells of organisms such as molluscs to control the concentration and distribution of iron, thus sculpting shell morphology and colouration. [18] [19] It also plays a role in the haemolymph of the polyplacophora, where it serves to rapidly transport iron to the mineralizing radula. [20]

Iron is released from ferritin for use by ferritin degradation, which is performed mainly by lysosomes. [21]

Ferroxidase activity

Vertebrate ferritin consists of two or three subunits which are named based on their molecular weight: L "light", H "heavy", and M "middle" subunits. The M subunit has only been reported in bullfrogs. In bacteria and archaea, ferritin consists of one subunit type. [22] H and M subunits of eukaryotic ferritin and all subunits of bacterial and archaeal ferritin are H-type and have ferroxidase activity, which means they are able to convert iron from the ferrous (Fe2+) to ferric (Fe3+) forms. This limits the deleterious reaction which occurs between ferrous iron and hydrogen peroxide known as the Fenton reaction which produces the highly damaging hydroxyl radical. The ferroxidase activity occurs at a diiron binding site in the middle of each H-type subunits. [22] [23] After oxidation of Fe(II), the Fe(III) product stays metastably in the ferroxidase center and is displaced by Fe(II), [23] [24] a mechanism that appears to be common among ferritins of all three domains of life. [22] The light chain of ferritin has no ferroxidase activity but may be responsible for the electron transfer across the protein cage. [25]

Immune response

Ferritin concentrations increase drastically in the presence of an infection or cancer. Endotoxins are an up-regulator of the gene coding for ferritin, thus causing the concentration of ferritin to rise. By contrast, organisms such as Pseudomonas, although possessing endotoxin, cause plasma ferritin levels to drop significantly within the first 48 hours of infection. Thus, the iron stores of the infected body are denied to the infective agent, impeding its metabolism. [26]

Stress response

The concentration of ferritin has been shown to increase in response to stresses such as anoxia, [27] which implies that it is an acute phase protein. [28]

Mitochondria

Mitochondrial ferritin has many roles pertaining to molecular function. It participates in ferroxidase activity, binding, iron ion binding, oxidoreductase activity, ferric iron binding, metal ion binding as well as transition metal binding. Within the realm of biological processes it participates in oxidation-reduction, iron ion transport across membranes and cellular iron ion homeostasis.[ citation needed ]

Yolk

In some snails, the protein component of the egg yolk is primarily ferritin. [29] This is a different ferritin, with a different genetic sequence, from the somatic ferritin. It is produced in the midgut glands and secreted into the haemolymph, whence it is transported to the eggs. [29]

Tissue distribution

In vertebrates, ferritin is usually found within cells, although it is also present in smaller quantities in the plasma. [26]

Diagnostic uses

Serum ferritin levels are measured in medical laboratories as part of the iron studies workup for iron-deficiency anemia. [6] They are measured in nanograms per milliliter (ng/mL) or micrograms per liter (μg/L); the two units are equivalent.

The ferritin levels measured usually have a direct correlation with the total amount of iron stored in the body. However, ferritin levels may be artificially high in cases of anemia of chronic disease, where ferritin is elevated in its capacity as an inflammatory acute phase protein and not as a marker for iron overload.[ citation needed ]

Normal ranges

A normal ferritin blood level, referred to as the reference interval is determined by many testing laboratories. The ranges for ferritin can vary between laboratories but typical ranges would be between 40 and 300 ng/mL (=μg/L) for males, and 20–200 ng/mL (=μg/L) for females. [30]

Normal ferritin blood levels according to sex and age[ citation needed ]
Adult males40–300 ng/mL (μg/L) [30]
Adult females20–200 ng/mL (μg/L) [30]
Children (6 months to 15 years)50–140 ng/mL (μg/L)
Infants (1 to 5 months)50–200 ng/mL (μg/L)
Neonates25–200 ng/mL (μg/L)

Deficiency

According to a 2014 review in the New England Journal of Medicine stated that a ferritin level below 30 ng/mL indicates iron deficiency, while a level below 10 ng/mL indicates iron-deficiency anemia. [30] A 2020 World Health Organization guideline states that ferritin indicates iron deficiency below 12 ng/mL in apparently-healthy children under 5 and 15 ng/mL in apparently-healthy individuals of 5 and over. [31]

Some studies suggest that women with fatigue and ferritin below 50 ng/mL see reduced fatigue after iron supplementation. [32] [33]

In the setting of anemia, low serum ferritin is the most specific lab finding for iron-deficiency anemia. [34] However it is less sensitive, since its levels are increased in the blood by infection or any type of chronic inflammation, [35] and these conditions may convert what would otherwise be a low level of ferritin from lack of iron, into a value in the normal range. For this reason, low ferritin levels carry more information than those in the normal range. A falsely low blood ferritin (equivalent to a false positive test) is very uncommon, [35] but can result from a hook effect of the measuring tools in extreme cases. [36]

Low ferritin may also indicate hypothyroidism, [37] vitamin C deficiency or celiac disease.[ citation needed ]

Low serum ferritin levels are seen in some patients with restless legs syndrome, not necessarily related to anemia, but perhaps due to low iron stores short of anemia. [38] [39]

Vegetarianism is not a cause of low serum ferritin levels, according to the American Dietetic Association's position in 2009: "Incidence of iron-deficiency anemia among vegetarians is similar to that of non-vegetarians. Although vegetarian adults have lower iron stores than non-vegetarians, their serum ferritin levels are usually within the normal range." [40]

Excess

If ferritin is high, there is iron in excess or else there is an acute inflammatory reaction in which ferritin is mobilized without iron excess. For example, ferritins may be high in infection without signaling body iron overload.

Ferritin is also used as a marker for iron overload disorders, such as hemochromatosis or hemosiderosis. Adult-onset Still's disease, some porphyrias, and hemophagocytic lymphohistiocytosis/macrophage activation syndrome are diseases in which the ferritin level may be abnormally raised.

As ferritin is also an acute-phase reactant, it is often elevated in the course of disease. A normal C-reactive protein can be used to exclude elevated ferritin caused by acute phase reactions. [ citation needed ]

Ferritin has been shown to be elevated in some cases of COVID-19 and may correlate with worse clinical outcome. [41] [42] Ferritin and IL-6 are considered to be possible immunological biomarkers for severe and fatal cases of COVID-19. Ferritin and C-reactive protein may be possible screening tools for early diagnosis of systemic inflammatory response syndrome in cases of COVID-19. [43] [44]

According to a study of anorexia nervosa patients, ferritin can be elevated during periods of acute malnourishment, perhaps due to iron going into storage as intravascular volume and thus the number of red blood cells falls. [45]

Another study suggests that due to the catabolic nature of anorexia nervosa, isoferritins may be released. Furthermore, ferritin has significant non-storage roles within the body, such as protection from oxidative damage. The rise of these isoferritins may contribute to an overall increase in ferritin concentration. The measurement of ferritin through immunoassay or immunoturbidimeteric methods may also be picking up these isoferritins thus not a true reflection of iron storage status. [46]

Studies reveal that a transferrin saturation (serum iron concentration ÷ total iron binding capacity) over 60 percent in men and over 50 percent in women identified the presence of an abnormality in iron metabolism (hereditary hemochromatosis, heterozygotes, and homozygotes) with approximately 95 percent accuracy. This finding helps in the early diagnosis of hereditary hemochromatosis, especially while serum ferritin still remains low. The retained iron in hereditary hemochromatosis is primarily deposited in parenchymal cells, with reticuloendothelial cell accumulation occurring very late in the disease. This is in contrast to transfusional iron overload in which iron deposition occurs first in the reticuloendothelial cells and then in parenchymal cells. This explains why ferritin levels remain relative low in hereditary hemochromatosis, while transferrin saturation is high. [47] [48]

In chronic liver diseases

Hematological abnormalities often associate with chronic liver diseases. Both iron overload and iron deficient anemia have been reported in patients with liver cirrhosis. [49] [50] The former is mainly due to reduced hepcidin level caused by the decreased synthetic capacity of the liver, while the latter is due to acute and chronic bleeding caused by portal hypertension. Inflammation is also present in patients with advanced chronic liver disease. As a consequence, elevated hepatic and serum ferritin levels are consistently reported in chronic liver diseases. [51] [52] [53]

Studies showed association between high serum ferritin levels and increased risk of short-term mortality in cirrhotic patients with acute decompensation [54] and acute-on-chronic liver failure. [55] An other study found association between high serum ferritin levels and increased risk of long-term mortality in compensated and stable decompensated cirrhotic patients. [56] The same study demonstrated that increased serum ferritin levels could predict the development of bacterial infection in stable decompensated cirrhotic patients, while in compensated cirrhotic patients the appearance of the very first acute decompensation episode showed higher incidence in patients with low serum ferritin levels. This latter finding was explained by the association between chronic bleeding and increased portal pressure. [56]

Discovery

Ferritin was discovered in 1937 by the Czechoslovakian scientist Vilém Laufberger  [ cs ]. [57] [7] :e9 Sam Granick and Leonor Michaelis produced apoferritin in 1942 [7] :e10

Applications

Ferritin is used in materials science as a precursor in making iron nanoparticles (NP) for carbon nanotube growth by chemical vapor deposition.

Cavities formed by ferritin and mini-ferritins (Dps) proteins have been successfully used as the reaction chamber for the fabrication of metal nanoparticles. [58] [59] [60] [61] Protein shells served as a template to restrain particle growth and as a coating to prevent coagulation/aggregation between NPs. Using various sizes of protein shells, various sizes of NPs can be easily synthesized for chemical, physical and bio-medical applications. [6] [62]

Experimental COVID-19 vaccines have been produced that display the spike protein's receptor binding domain on the surface of ferritin nanoparticles. [63]

Notes

The primary peptide sequence of human ferritin is: [64]

MTTASTSQVR QNYHQDSEAA INRQINLELY ASYVYLSMSY YFDRDDVALK NFAKYFLHQS HEEREHAEKL MKLQNQRGGR IFLQDIKKPD CDDWESGLNA MECALHLEKN VNQSLLEFPS PISPSPSCWH HYTTNRPQPQ HHLLRPRRRK RPHSIPTPIL IFRSP. 

See also

Related Research Articles

<span class="mw-page-title-main">Hereditary haemochromatosis</span> Medical condition

Hereditary haemochromatosis type 1 is a genetic disorder characterized by excessive intestinal absorption of dietary iron, resulting in a pathological increase in total body iron stores. Humans, like most animals, have no mechanism to regulate excess iron, simply losing a limited amount through various means like sweating or menstruating.

<span class="mw-page-title-main">Anemia</span> Reduced ability of blood to carry oxygen

Anemia or anaemia is a blood disorder in which the blood has a reduced ability to carry oxygen. This can be due to a lower than normal number of red blood cells, a reduction in the amount of hemoglobin available for oxygen transport, or abnormalities in hemoglobin that impair its function.

<span class="mw-page-title-main">Iron deficiency</span> State in which a body lacks enough iron to supply its needs

Iron deficiency, or sideropenia, is the state in which a body lacks enough iron to supply its needs. Iron is present in all cells in the human body and has several vital functions, such as carrying oxygen to the tissues from the lungs as a key component of the hemoglobin protein, acting as a transport medium for electrons within the cells in the form of cytochromes, and facilitating oxygen enzyme reactions in various tissues. Too little iron can interfere with these vital functions and lead to morbidity and death.

<span class="mw-page-title-main">Transferrin</span> Mammalian protein found in Homo sapiens

Transferrins are glycoproteins found in vertebrates which bind and consequently mediate the transport of iron (Fe) through blood plasma. They are produced in the liver and contain binding sites for two Fe3+ ions. Human transferrin is encoded by the TF gene and produced as a 76 kDa glycoprotein.

<span class="mw-page-title-main">Iron overload</span> Human disease

Iron overload is the abnormal and increased accumulation of total iron in the body, leading to organ damage. The primary mechanism of organ damage is oxidative stress, as elevated intracellular iron levels increase free radical formation via the Fenton reaction. Iron overload is often primary but may also be secondary to repeated blood transfusions. Iron deposition most commonly occurs in the liver, pancreas, skin, heart, and joints. People with iron overload classically present with the triad of liver cirrhosis, secondary diabetes mellitus, and bronze skin. However, due to earlier detection nowadays, symptoms are often limited to general chronic malaise, arthralgia, and hepatomegaly.

<span class="mw-page-title-main">Iron-deficiency anemia</span> Reduced ability of the blood to carry oxygen due to a lack of iron

Iron-deficiency anemia is anemia caused by a lack of iron. Anemia is defined as a decrease in the number of red blood cells or the amount of hemoglobin in the blood. When onset is slow, symptoms are often vague such as feeling tired, weak, short of breath, or having decreased ability to exercise. Anemia that comes on quickly often has more severe symptoms, including confusion, feeling like one is going to pass out or increased thirst. Anemia is typically significant before a person becomes noticeably pale. Children with iron deficiency anemia may have problems with growth and development. There may be additional symptoms depending on the underlying cause.

<span class="mw-page-title-main">Microcytic anemia</span> Medical condition

Microcytic anaemia is any of several types of anemia characterized by smaller than normal red blood cells. The normal mean corpuscular volume is approximately 80–100 fL. When the MCV is <80 fL, the red cells are described as microcytic and when >100 fL, macrocytic. The MCV is the average red blood cell size.

Anemia of chronic disease (ACD) or anemia of chronic inflammation is a form of anemia seen in chronic infection, chronic immune activation, and malignancy. These conditions all produce elevation of interleukin-6, which stimulates hepcidin production and release from the liver. Hepcidin production and release shuts down ferroportin, a protein that controls export of iron from the gut and from iron storing cells. As a consequence, circulating iron levels are reduced. Other mechanisms may also play a role, such as reduced erythropoiesis. It is also known as anemia of inflammation, or anemia of inflammatory response.

<span class="mw-page-title-main">Total iron-binding capacity</span> Medical blood test to measure transferrin

Total iron-binding capacity (TIBC) or sometimes transferrin iron-binding capacity is a medical laboratory test that measures the blood's capacity to bind iron with transferrin. Transferrin can bind two atoms of ferric iron (Fe3+) with high affinity. It means that transferrin has the capacity to transport approximately from 1.40 to 1.49 mg of iron per gram of transferrin present in the blood.

Transferrin saturation (TS), measured as a percentage, is a medical laboratory value. It is the value of serum iron divided by the total iron-binding capacity of the available transferrin, the main protein that binds iron in the blood, this value tells a clinician how much serum iron is bound. For instance, a value of 15% means that 15% of iron-binding sites of transferrin are being occupied by iron. The three results are usually reported together. A low transferrin saturation is a common indicator of iron deficiency anemia whereas a high transferrin saturation may indicate iron overload or hemochromatosis. Transferrin saturation is also called transferrin saturation index (TSI) or transferrin saturation percentage (TS%)

<span class="mw-page-title-main">Human iron metabolism</span> Iron metabolism in the body

Human iron metabolism is the set of chemical reactions that maintain human homeostasis of iron at the systemic and cellular level. Iron is both necessary to the body and potentially toxic. Controlling iron levels in the body is a critically important part of many aspects of human health and disease. Hematologists have been especially interested in systemic iron metabolism, because iron is essential for red blood cells, where most of the human body's iron is contained. Understanding iron metabolism is also important for understanding diseases of iron overload, such as hereditary hemochromatosis, and iron deficiency, such as iron-deficiency anemia.

<span class="mw-page-title-main">Hepcidin</span> Protein-coding gene in the species Homo sapiens

Hepcidin is a protein that in humans is encoded by the HAMP gene. Hepcidin is a key regulator of the entry of iron into the circulation in mammals.

<span class="mw-page-title-main">Ferroportin</span> Protein

Ferroportin-1, also known as solute carrier family 40 member 1 (SLC40A1) or iron-regulated transporter 1 (IREG1), is a protein that in humans is encoded by the SLC40A1 gene. Ferroportin is a transmembrane protein that transports iron from the inside of a cell to the outside of the cell. Ferroportin is the only known iron exporter.

<span class="mw-page-title-main">African iron overload</span> Iron overload disorder caused by consumption of home-brewed beer

African iron overload is an iron overload disorder first observed among people of African descent in Southern Africa and Central Africa. It is now recognized to actually be two disorders with different causes, possibly compounding each other:

<span class="mw-page-title-main">Beta thalassemia</span> Blood disorder

Beta thalassemias are a group of inherited blood disorders. They are forms of thalassemia caused by reduced or absent synthesis of the beta chains of hemoglobin that result in variable outcomes ranging from severe anemia to clinically asymptomatic individuals. Global annual incidence is estimated at one in 100,000. Beta thalassemias occur due to malfunctions in the hemoglobin subunit beta or HBB. The severity of the disease depends on the nature of the mutation.

<span class="mw-page-title-main">Ferritin light chain</span> Protein found in humans

Ferritin light chain is a protein that in humans is encoded by the FTL gene. Ferritin is the major protein responsible for storing intracellular iron in prokaryotes and eukaryotes. It is a heteropolymer consisting of 24 subunits, heavy and light ferritin chains. This gene has multiple pseudogenes.

<span class="mw-page-title-main">Hemosiderosis</span> Medical condition, an iron metabolism disease

Hemosiderosis is a form of iron overload disorder resulting in the accumulation of hemosiderin.

Soluble transferrin receptor conventionally refers to the cleaved extracellular portion of transferrin receptor 1 that is released into serum. This receptor is a protein dimer of two identical subunits, linked together by two pairs of disulfide bonds. Its molecular mass 190,000 Dalton.

Hemochromatosis type 4 is a hereditary iron overload disorder that affects ferroportin, an iron transport protein needed to export iron from cells into circulation. Although the disease is rare, it is found throughout the world and affects people from various ethnic groups. While the majority of individuals with type 4 hemochromatosis have a relatively mild form of the disease, some affected individuals have a more severe form. As the disease progresses, iron may accumulate in the tissues of affected individuals over time, potentially resulting in organ damage.

Iron preparation is the formulation for iron supplements indicated in prophylaxis and treatment of iron-deficiency anemia. Examples of iron preparation include ferrous sulfate, ferrous gluconate, and ferrous fumarate. It can be administered orally, and by intravenous injection, or intramuscular injection.

References

  1. PDB: 1lb3 ; Granier T, Langlois d'Estaintot B, Gallois B, Chevalier JM, Précigoux G, Santambrogio P, et al. (January 2003). "Structural description of the active sites of mouse L-chain ferritin at 1.2 A resolution". Journal of Biological Inorganic Chemistry. 8 (1–2): 105–111. doi:10.1007/s00775-002-0389-4. PMID   12459904. S2CID   20756710.
  2. PDB: 1r03 ; Langlois d'Estaintot B, Santambrogio P, Granier T, Gallois B, Chevalier JM, Précigoux G, et al. (July 2004). "Crystal structure and biochemical properties of the human mitochondrial ferritin and its mutant Ser144Ala". Journal of Molecular Biology. 340 (2): 277–293. doi:10.1016/j.jmb.2004.04.036. PMID   15201052.
  3. Casiday R, Frey R. "Iron Use and Storage in the Body: Ferritin and Molecular Representations". Department of Chemistry, Washington University in St. Louis.
  4. Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV (August 2010). "Serum ferritin: Past, present and future". Biochimica et Biophysica Acta (BBA) - General Subjects. 1800 (8): 760–769. doi:10.1016/j.bbagen.2010.03.011. PMC   2893236 . PMID   20304033.
  5. MacKenzie EL, Iwasaki K, Tsuji Y (June 2008). "Intracellular iron transport and storage: from molecular mechanisms to health implications". Antioxidants & Redox Signaling. 10 (6): 997–1030. doi:10.1089/ars.2007.1893. PMC   2932529 . PMID   18327971.
  6. 1 2 3 Theil EC (2012). "Ferritin protein nanocages-the story". Nanotechnology Perceptions. 8 (1): 7–16. doi:10.4024/N03TH12A.ntp.08.01. PMC   3816979 . PMID   24198751.
  7. 1 2 3 Kresge N, Simoni RD, Hill RL (2004). "The Characterization of Ferritin and Apoferritin by Leonor Michaelis and Sam Granick". Journal of Biological Chemistry. 279 (49). Elsevier BV: e9–e11. doi: 10.1016/s0021-9258(20)69471-6 . ISSN   0021-9258.
  8. Torti FM, Torti SV (May 2002). "Regulation of ferritin genes and protein". Blood. 99 (10): 3505–3516. doi: 10.1182/blood.V99.10.3505 . PMID   11986201.
  9. 1 2 3 4 5 6 Theil EC (1987). "Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms". Annual Review of Biochemistry. 56 (1): 289–315. doi:10.1146/annurev.bi.56.070187.001445. PMID   3304136.
  10. De Zoysa M, Lee J (September 2007). "Two ferritin subunits from disk abalone (Haliotis discus discus): cloning, characterization and expression analysis". Fish & Shellfish Immunology. 23 (3): 624–635. Bibcode:2007FSI....23..624D. doi:10.1016/j.fsi.2007.01.013. PMID   17442591.
  11. "Ferritin Structure and Its Biomedical Implications". Metallic BioNano Particles. Universidad de Granada. Archived from the original on 2016-08-27. Retrieved 2016-01-16.
  12. 1 2 3 4 5 6 7 8 Andrews SC, Arosio P, Bottke W, Briat JF, von Darl M, Harrison PM, et al. (1992). "Structure, function, and evolution of ferritins". Journal of Inorganic Biochemistry. 47 (3–4): 161–174. doi:10.1016/0162-0134(92)84062-R. PMID   1431878.
  13. Zhang Y, Meng Q, Jiang T, Wang H, Xie L, Zhang R (May 2003). "A novel ferritin subunit involved in shell formation from the pearl oyster (Pinctada fucata)". Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology. 135 (1): 43–54. doi:10.1016/S1096-4959(03)00050-2. PMID   12781972.
  14. Levi S, Corsi B, Bosisio M, Invernizzi R, Volz A, Sanford D, et al. (July 2001). "A human mitochondrial ferritin encoded by an intronless gene". The Journal of Biological Chemistry. 276 (27): 24437–24440. doi: 10.1074/jbc.C100141200 . PMID   11323407.
  15. Lovell SC, Davis IW, Arendall WB, de Bakker PI, Word JM, Prisant MG, et al. (February 2003). "Structure validation by Calpha geometry: phi,psi and Cbeta deviation" (PDF). Proteins. 50 (3): 437–450. doi:10.1002/prot.10286. PMID   12557186. S2CID   8358424. Archived from the original (PDF) on 12 October 2012. MolProbity Ramachandran analysis
  16. Seckback J (1982). "Ferreting out the secrets of plant ferritin - A review". Journal of Plant Nutrition. 5 (4–7): 369–394. Bibcode:1982JPlaN...5..369S. doi:10.1080/01904168209362966.
  17. Orino K, Lehman L, Tsuji Y, Ayaki H, Torti SV, Torti FM (July 2001). "Ferritin and the response to oxidative stress". The Biochemical Journal. 357 (Pt 1): 241–247. doi:10.1042/0264-6021:3570241. PMC   1221947 . PMID   11415455.
  18. Jackson DJ, Wörheide G, Degnan BM (September 2007). "Dynamic expression of ancient and novel molluscan shell genes during ecological transitions". BMC Evolutionary Biology. 7 (1): 160. Bibcode:2007BMCEE...7..160J. doi: 10.1186/1471-2148-7-160 . PMC   2034539 . PMID   17845714.
  19. Yano M, Nagai K, Morimoto K, Miyamoto H (June 2006). "Shematrin: a family of glycine-rich structural proteins in the shell of the pearl oyster Pinctada fucata". Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology. 144 (2): 254–262. doi:10.1016/j.cbpb.2006.03.004. PMID   16626988.
  20. Kyung-Suk K, Webb J, Macey D (1986). "Properties and role of ferritin in the hemolymph of the chiton Clavarizona hirtosa". Biochimica et Biophysica Acta (BBA) - General Subjects. 884 (3): 387–394. doi:10.1016/0304-4165(86)90188-1.
  21. Zhang Y, Mikhael M, Xu D, Li Y, Soe-Lin S, Ning B, et al. (October 2010). "Lysosomal proteolysis is the primary degradation pathway for cytosolic ferritin and cytosolic ferritin degradation is necessary for iron exit". Antioxidants & Redox Signaling. 13 (7): 999–1009. doi:10.1089/ars.2010.3129. PMID   20406137.
  22. 1 2 3 Honarmand Ebrahimi K, Hagedoorn PL, Hagen WR (January 2015). "Unity in the biochemistry of the iron-storage proteins ferritin and bacterioferritin". Chemical Reviews. 115 (1): 295–326. doi: 10.1021/cr5004908 . PMID   25418839.
  23. 1 2 Honarmand Ebrahimi K, Bill E, Hagedoorn PL, Hagen WR (November 2012). "The catalytic center of ferritin regulates iron storage via Fe(II)-Fe(III) displacement". Nature Chemical Biology. 8 (11): 941–948. doi:10.1038/nchembio.1071. PMID   23001032.
  24. Watt RK (March 2013). "A unified model for ferritin iron loading by the catalytic center: implications for controlling "free iron" during oxidative stress". ChemBioChem. 14 (4): 415–419. doi:10.1002/cbic.201200783. PMID   23404831. S2CID   41485685.
  25. Carmona U, Li L, Zhang L, Knez M (December 2014). "Ferritin light-chain subunits: key elements for the electron transfer across the protein cage". Chemical Communications. 50 (97): 15358–15361. doi:10.1039/c4cc07996e. PMID   25348725.
  26. 1 2 Ong DS, Wang L, Zhu Y, Ho B, Ding JL (2005). "The response of ferritin to LPS and acute phase of Pseudomonas infection". Journal of Endotoxin Research. 11 (5): 267–280. doi:10.1179/096805105X58698. PMID   16262999.
  27. Larade K, Storey KB (March 2004). "Accumulation and translation of ferritin heavy chain transcripts following anoxia exposure in a marine invertebrate". The Journal of Experimental Biology. 207 (Pt 8): 1353–1360. doi: 10.1242/jeb.00872 . PMID   15010486.
  28. Beck G, Ellis TW, Habicht GS, Schluter SF, Marchalonis JJ (January 2002). "Evolution of the acute phase response: iron release by echinoderm (Asterias forbesi) coelomocytes, and cloning of an echinoderm ferritin molecule". Developmental and Comparative Immunology. 26 (1): 11–26. doi:10.1016/S0145-305X(01)00051-9. PMID   11687259.
  29. 1 2 Bottke W, Burschyk M, Volmer J (December 1988). "On the origin of the yolk protein ferritin in snails". Roux's Archives of Developmental Biology. 197 (7): 377–382. doi:10.1007/BF00398988. PMID   28305744. S2CID   34033340.
  30. 1 2 3 4 Camaschella C (May 2015). Longo DL (ed.). "Iron-deficiency anemia". The New England Journal of Medicine. 372 (19): 1832–1843. doi:10.1056/NEJMra1401038. PMID   25946282. S2CID   17628280.
  31. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. Geneva, Switzerland: World Health Organization. 2020. ISBN   978-92-4-000012-4. OCLC   1265083396.
  32. Verdon F, Burnand B, Stubi CL, Bonard C, Graff M, Michaud A, et al. (May 2003). "Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial". BMJ. 326 (7399): 1124–0. doi:10.1136/bmj.326.7399.1124. PMC   156009 . PMID   12763985.
  33. Vaucher P, Druais PL, Waldvogel S, Favrat B (August 2012). "Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial". CMAJ. 184 (11): 1247–1254. doi:10.1503/cmaj.110950. PMC   3414597 . PMID   22777991.
  34. Guyatt GH, Patterson C, Ali M, Singer J, Levine M, Turpie I, et al. (March 1990). "Diagnosis of iron-deficiency anemia in the elderly". The American Journal of Medicine. 88 (3): 205–209. doi:10.1016/0002-9343(90)90143-2. PMID   2178409.
  35. 1 2 Firkin F, Rush B (1997). "Interpretation of biochemical tests for iron deficiency: diagnostic difficulties related to limitations of individual tests". Australian Prescriber. 20: 74–6. doi: 10.18773/austprescr.1997.063 . Archived from the original on 2012-03-25.{{cite journal}}: CS1 maint: unfit URL (link)
  36. Burnett D, Crocker JR (1999). The Science of Laboratory Diagnosis. ISIS Medical Media. p. 341. ISBN   978-1-899066-62-9.
  37. R V, Dhiman P, Kollipaka R, P S, V H (August 2022). "Association of Hypothyroidism With Low Serum Ferritin Levels and Iron-Deficiency Anemia During the First Trimester of Pregnancy". Cureus. 14 (8): e28307. doi: 10.7759/cureus.28307 . PMC   9498961 . PMID   36158423.
  38. Kryger MH, Otake K, Foerster J (March 2002). "Low body stores of iron and restless legs syndrome: a correctable cause of insomnia in adolescents and teenagers". Sleep Medicine. 3 (2): 127–132. doi:10.1016/S1389-9457(01)00160-5. PMID   14592231.
  39. Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J (March 2005). "CSF iron, ferritin and transferrin levels in restless legs syndrome". Journal of Sleep Research. 14 (1): 43–47. doi: 10.1111/j.1365-2869.2004.00403.x . PMID   15743333. S2CID   12959227.
  40. Craig WJ, Mangels AR (July 2009). "Position of the American Dietetic Association: vegetarian diets". Journal of the American Dietetic Association. 109 (7): 1266–1282. doi:10.1016/j.jada.2009.05.027. PMID   19562864. S2CID   7906168.
  41. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. (May 2020). "Clinical and immunological features of severe and moderate coronavirus disease 2019". The Journal of Clinical Investigation. 130 (5): 2620–2629. doi: 10.1172/JCI137244 . PMC   7190990 . PMID   32217835.
  42. Zachariah M, Maamoun H, Milano L, Rayman MP, Meira LB, Agouni A (June 2021). "Endoplasmic reticulum stress and oxidative stress drive endothelial dysfunction induced by high selenium". Journal of Cellular Physiology. 236 (6): 4348–4359. doi: 10.1080/20905068.2020.1870788 . PMC   8108185 . PMID   33241572.
  43. Melo AK, Milby KM, Caparroz AL, Pinto AC, Santos RR, Rocha AP, et al. (29 June 2021). "Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis". PLOS ONE. 16 (6): e0253894. Bibcode:2021PLoSO..1653894M. doi: 10.1371/journal.pone.0253894 . PMC   8241122 . PMID   34185801.
  44. Dance A (10 April 2020). "What is a cytokine storm?". Knowable Magazine. Annual Reviews. Retrieved 9 August 2021.
  45. Kennedy A, Kohn M, Lammi A, Clarke S (August 2004). "Iron status and haematological changes in adolescent female inpatients with anorexia nervosa". Journal of Paediatrics and Child Health. 40 (8): 430–432. doi:10.1111/j.1440-1754.2004.00432.x. PMID   15265182. S2CID   26269832.
  46. Tran J, Story C, Moore D, Metz M (September 2013). "Unexpected increased ferritin concentration in patients with anorexia nervosa". Annals of Clinical Biochemistry. 50 (Pt 5): 504–506. doi: 10.1177/0004563213490289 . PMID   23897102. S2CID   9927714.
  47. Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS (July 2011). "Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases". Hepatology. 54 (1): 328–343. doi:10.1002/hep.24330. PMC   3149125 . PMID   21452290.
  48. "Hemochromatosis". guidelinecentral.com.
  49. Cotler SJ, Bronner MP, Press RD, Carlson TH, Perkins JD, Emond MJ, et al. (August 1998). "End-stage liver disease without hemochromatosis associated with elevated hepatic iron index". Journal of Hepatology. 29 (2): 257–262. doi:10.1016/S0168-8278(98)80011-1. PMID   9722207.
  50. Gkamprela E, Deutsch M, Pectasides D (2017). "Iron deficiency anemia in chronic liver disease: etiopathogenesis, diagnosis and treatment". Annals of Gastroenterology. 30 (4): 405–413. doi: 10.20524/aog.2017.0152 . PMC   5479992 . PMID   28655976.
  51. Guyader D, Thirouard AS, Erdtmann L, Rakba N, Jacquelinet S, Danielou H, et al. (April 2007). "Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C". Journal of Hepatology. 46 (4): 587–595. doi:10.1016/j.jhep.2006.09.021. PMID   17156889.
  52. Adams PC (1998). "Iron overload in viral and alcoholic liver disease". Journal of Hepatology. 28 (Suppl 1): 19–20. doi:10.1016/S0168-8278(98)80370-X. PMID   9575444.
  53. Eng SC, Taylor SL, Reyes V, Raaka S, Berger J, Kowdley KV (June 2005). "Hepatic iron overload in alcoholic end-stage liver disease is associated with iron deposition in other organs in the absence of HFE-1 hemochromatosis". Liver International. 25 (3): 513–517. doi:10.1111/j.1478-3231.2005.01004.x. PMID   15910487. S2CID   23125116.
  54. Maiwall R, Kumar S, Chaudhary AK, Maras J, Wani Z, Kumar C, et al. (July 2014). "Serum ferritin predicts early mortality in patients with decompensated cirrhosis". Journal of Hepatology. 61 (1): 43–50. doi:10.1016/j.jhep.2014.03.027. PMID   24681346.
  55. Maras JS, Maiwall R, Harsha HC, Das S, Hussain MS, Kumar C, et al. (April 2015). "Dysregulated iron homeostasis is strongly associated with multiorgan failure and early mortality in acute-on-chronic liver failure". Hepatology. 61 (4): 1306–1320. doi: 10.1002/hep.27636 . PMID   25475192.
  56. 1 2 Tornai D, Antal-Szalmas P, Tornai T, Papp M, Tornai I, Sipeki N, et al. (March 2021). "Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study". BMC Gastroenterology. 21 (1): 94. doi: 10.1186/s12876-021-01669-w . PMC   7923668 . PMID   33653274.
  57. Laufberger V (1937). "Sur la Cristallisation de la Ferritine". Bulletin de la Société de Chimie Biologique. 19: 1575–1582. ISSN   0037-9042.
  58. Kasyutich O, Ilari A, Fiorillo A, Tatchev D, Hoell A, Ceci P (March 2010). "Silver ion incorporation and nanoparticle formation inside the cavity of Pyrococcus furiosus ferritin: structural and size-distribution analyses". Journal of the American Chemical Society. 132 (10): 3621–3627. doi:10.1021/ja910918b. PMID   20170158.
  59. Uchida M, Flenniken ML, Allen M, Willits DA, Crowley BE, Brumfield S, et al. (December 2006). "Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles". Journal of the American Chemical Society. 128 (51): 16626–16633. doi:10.1021/ja0655690. PMID   17177411.
  60. Li M, Viravaidya C, Mann S (September 2007). "Polymer-mediated synthesis of ferritin-encapsulated inorganic nanoparticles". Small. 3 (9): 1477–1481. doi:10.1002/smll.200700199. PMID   17768776.
  61. Ueno T, Suzuki M, Goto T, Matsumoto T, Nagayama K, Watanabe Y (May 2004). "Size-selective olefin hydrogenation by a Pd nanocluster provided in an apo-ferritin cage". Angewandte Chemie. 43 (19): 2527–2530. doi:10.1002/anie.200353436. PMID   15127443.
  62. Stanford's Single-Dose Nanoparticle Vaccine for COVID-19. On: SciTechDaily. January 10, 2021. Source: Stanford University
  63. Wang W, Huang B, Zhu Y, Tan W, Zhu M (March 2021). "Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice". Cellular & Molecular Immunology. 18 (3): 749–751. doi:10.1038/s41423-021-00643-6. PMC   7880661 . PMID   33580169.
  64. "Ferritin - Homo sapiens (Human)". UniProt. Q8TD27.